Gordon Lorimer to Lead Cambio Healthcare Systems in UK and Ireland

Cambio Healthcare SystemsExperienced healthcare technology company leader Gordon Lorimer has been appointed as managing director for Cambio Healthcare Systems in the UK and Ireland to grow the Swedish firm's EPR presence in the region.

With over a decade working at the forefront of health IT for firms such as NCR Healthcare, iSOFT and Intouch with Health, Lorimer brings with him a breadth and depth of knowledge and wide range of contacts from across the healthcare sector.

He will look to build on the success Cambio has had in the Nordic region, where it is a fundamental part of the technology-enabled integrated care model that the UK is looking to emulate, and which was reiterated in the recent Spending Review.

Building on the NHS Five Year Forward View, Chancellor George Osborne promised investment of £1bn in health technology over five years, so that by 2020 integrated care records will give every health and care professional concerned with an individual’s care the information they need to provide safe and prompt care.

Cambio COSMIC, which has been in use in The Princess Alexandra Hospital NHS Trust since 2014, has impressive credentials to help achieve this vision. COSMIC works with half of Sweden's public healthcare organisations, and supports a single patient record in use across Greenland and the Faroe Islands for all health and care providers through to tertiary care hospitals. In Denmark, the COSMIC system in Region South has 23,000 registered users, proving Cambio can support large complex implementations with multiple users from across health and social care.

Lorimer will apply his energy and belief in the benefit that healthcare IT can bring to promote Cambio’s COSMIC electronic patient record (EPR) system, its patient administration system (PAS) and clinical decision support solutions, to the acute, community, mental health, social and patient portal markets in the UK, and show how it can help health and care economies deliver technology-enabled person-centred care.

"Cambio has the technology and the team that can make the most impact for patients across multiple care providers," he said. "There is a great deal of similarity in the leading EPR systems' functionality, however Cambio is different because we work very closely with our customers to help them achieve what they want to achieve and at a cost that is easily justified. We do this by using a substantial product development capability coupled with a proven implantation methodology to support the future of health and care delivery. Cambio is capable and caring with experienced highly skilled staff dedicated to working in a true partnership with our customers."

Cambio's COSMIC EPR is an open modular system that supports clinical and administrative processes across healthcare organisations of all sizes and care settings. It can scale according to the emerging needs of NHS and other care providers, so that it can support their patient safety, integrated care and clinical efficiency ambitions.

Cambio is a founding member of the openEHR foundation. The system has been developed to support the integrated care delivery models in use across the Nordics, building on its Swedish roots. Integrating care around the needs of the individual is a priority for the UK government, and was a key theme for the recent Spending Review. Ireland, too, is looking to deliver more person-centred care.

From its work at Princess Alexandra and private healthcare providers, Cambio has the UK infrastructure in place, and a product developed with extensive healthcare input, that can help the NHS and other health and social care providers meet these ambitions.

Cambio also has the insight to meet the emerging needs of UK health and social care, with its increasing focus on involving patients in their own care.

"Getting the patient more involved in their care will be extremely important going forward, with patient portals coming to the fore," said Lorimer. "Our system can support this, as well as deliver clinical decision support solutions that can recommend the best in care. Cambio already supports such delivery of care in the Nordic market; we can offer this to the UK and Ireland as well."

Tomas Mora-Morrison, founder and innovation director, Cambio Healthcare Systems said: "Gordon will now play a key role in helping to grow the market in the UK and Ireland. We believe his strong track record provides the credentials to enable him to achieve this, whilst his passion for healthcare technology fits well with our culture of delivering services and solutions that can bring about real change for our customers. We look forward to working with healthcare providers to demonstrate how we can help them realise their goals at scale and pace, and at a cost that is affordable to meet their specific needs."

Lorimer moved into healthcare IT after several years in the City. He then worked across primary, secondary and mental health care settings, and experienced the NHS' National Programme for IT.

As managing director of Intouch with Health, he established and led a new company division that grew to become the core part of the re-born and rejuvenated business. This was a significant turnaround and led to impressive business growth for the supplier of self service and patient flow management solutions to the NHS acute sector. He took them to be market leader in terms of the number of kiosks used by NHS acute trusts.

At Cambio, Lorimer will focus the business on where its solutions can deliver a major difference to patient safety and organisational efficiency in creating strong safe solutions to demanding Customer requirements.

"We want to grow at a pace in the UK and Ireland that allows us to do what we do best - high quality complex implementations that make the most use of our functionally rich, but useable, clinical systems and realise the enormous potential of digital healthcare," said Lorimer.

About Cambio Healthcare Systems
Cambio Healthcare Systems is a market leading Electronic Patient Record (EPR) company headquartered in Stockholm, Sweden with offices in the UK, Sweden, Denmark and Sri-Lanka. Cambio COSMIC® is a patient-centred integrated EPR system for comprehensive and clinical healthcare solutions with a focus on patient safety. Cambio COSMIC® offers solutions within all healthcare sectors and is used by over 100,000 clinicians and healthcare professionals. COSMIC® has been deployed as a single hospital site and as a regional system across primary, secondary and community care settings.

About Cambio
CAMBIO empowers healthcare providers to deliver better, safer patient care. It does this through its COSMIC EPR that delivers value for money through an intuitive, integrated and scalable platform. Designed to support clinical and administrative processes across healthcare organisations of all sizes and care settings, the system enables the ability to transform patient care and outcomes, whilst significantly improving efficiencies whilst achieving government targets.

About COSMIC
Cambio's COSMIC is a proven EPR that can be deployed to a time and scale to support the changing needs of the organisation and the health and care economy as a whole. It can help healthcare providers across the UK and Ireland to deliver improvements in:

  • Patient safety - Cambio COSMIC improves patient safety by reducing the number of adverse incidents due to human error, providing better accountability of actions and a safety net for healthcare providers.
  • Clinical efficacy - Cambio COSMIC improves clinical outcomes by supporting evidence-based medicine through the capture of coded clinical data across all aspects of healthcare delivery, the ability to analyse this information to drive and facilitate process change, and by decreasing deviation from clinical guidelines.
  • Improved efficiency - Cambio COSMIC saves costs and time associated with the reduction of paper and ad-hoc communication within healthcare organisations.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...